The DOI matches its Crossref record; 207 of the 207 references it cites were found in a registry or an index.
Sickle Cell Anemia, the First Molecular Disease: Overview of Molecular Etiology, Pathophysiology, and Therapeutic Approaches
Open accessAbstract
The root cause of sickle cell disease is a single β-globin gene mutation coding for the sickle β-hemoglobin chain. Sickle hemoglobin tetramers polymerize when deoxygenated, damaging the sickle erythrocyte. A multifaceted pathophysiology, triggered by erythrocyte injury induced by the sickle hemoglobin polymer, and encompassing more general cellular and tissue damage caused by hypoxia, oxidant damage, inflammation, abnormal intracellular interactions, and reduced nitric oxide bioavailability, sets off the events recognized clinically as sickle cell disease. This disease is a group of related disorders where sickle hemoglobin is the principal hemoglobin species. All have varying degrees of chronic hemolytic anemia, vasculopathy, vasoocclusive disease, acute and chronic organ damage, and shortened life span. Its complex pathophysiology, of which we have a reasonable understanding, provides multiple loci for potential therapeutic intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
Hacein-Bey-Abina, S., Von Kalle, C., Schmidt, M., McCormack, M. P., Wulffraat, N., Leboulch, P., Lim, A., Osborne, C. S., Pawliuk, R., Morillon, E., et al. (2003) · Science · doi:10.1126/science.1088547 · Cited by 3,587
Mortality in sickle cell disease. Life expectancy and risk factors for early death
Platt, O. S., Brambilla, D. J., Rosse, W. F., Milner, P. F., Castro, O., Steinberg, M. H., & Klug, P. P. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406093302303 · Cited by 3,320 · cited 1×
“Induction of HbF has been a goal of treating sickle cell disease for decades, since the clinical and laboratory observations that HbF inhibits HbS polymerization and that higher levels of HbF are associated with reduced mortality[137,138].”
BackgroundSelf-citationEffect of hydroxyurea on the frequency of painful crises in sickle cell anemia
Charache, S., Terrin, M. L., Moore, R. D., Dover, G. J., Barton, F. B., Eckert, S. V., McMahon, R. P., & Bonds, D. R. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505183322001 · Cited by 2,340
Sickle Cell Anemia, a Molecular Disease
Pauling, L., Itano, H. A., Singer, S. J., & Wells, I. C. (1949) · Science · doi:10.1126/science.110.2865.543 · Cited by 2,319 · cited 1×
“Because of this mutation, a valine residue replaces the normal glutamic acid residue (glu6val) and HbS β-globin chains are substituted for normal HbA β-globin chains[14,15].”
BackgroundAdams, R. J., McKie, V. C., Hsu, L., Files, B., Vichinsky, E., Pegelow, C., Abboud, M., Gallagher, D., Kutlar, A., Nichols, F. T., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807023390102 · Cited by 1,866
Rother, R. P., Bell, L., Hillmen, P., & Gladwin, M. T. (2005) · JAMA · doi:10.1001/jama.293.13.1653 · Cited by 1,557
Pain in Sickle Cell Disease: Rates and Risk Factors
Platt, O. S., Thorington, B. D., Brambilla, D. J., Milner, P. F., Rosse, W. F., Vichinsky, E., & Kinney, T. R. (1991) · New England Journal of Medicine · doi:10.1056/nejm199107043250103 · Cited by 1,546
Dams, R. O. J. A., Ie, V. I. C. M. C. K., Su, L. E. H., Iles, B. E. F., Ichinsky, E. L. V., Egelow, C. H. P., Bboud, M. I. A., Allagher, D. I. G., Utlar, K., Ichols, F. E. T. N., et al. (2015) · Cited by 1,338
Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
Reiter, C. D., Wang, X., Tanus-Santos, J. E., Hogg, N., Cannon, R. O., Schechter, A. N., & Gladwin, M. T. (2002) · Nature Medicine · doi:10.1038/nm1202-799 · Cited by 1,330
Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease
Gladwin, M. T., Sachdev, V., Jison, M. L., Shizukuda, Y., Plehn, J. F., Minter, K., Brown, B., Coles, W. A., Nichols, J. S., Ernst, I., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035477 · Cited by 1,325
Protection Afforded by Sickle-cell Trait Against Subtertian Malarial Infection
Allison, A. C. (1954) · BMJ · doi:10.1136/bmj.1.4857.290 · Cited by 1,291
Causes and Outcomes of the Acute Chest Syndrome in Sickle Cell Disease
Vichinsky, E. P., Neumayr, L. D., Earles, A. N., Williams, R., Lennette, E. T., Dean, D., Nickerson, B., Orringer, E., McKie, V., Bellevue, R., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006223422502 · Cited by 1,234
Pathogenesis and Treatment of Sickle Cell Disease
Bunn, H. F. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709113371107 · Cited by 1,154 · cited 1×
“Many reviews of sickle cell disease have been published, and entire books and scientific meeting proceedings have been devoted to this subject[1,2,3,4,5,6,7,8].”
BackgroundWeatherall, D. J., & Clegg, J. B. (2001) · Wiley eBooks · doi:10.1002/9780470696705 · Cited by 1,069
Steinberg, M. H., Barton, F., Castro, O., Pegelow, C. H., Ballas, S. K., Kutlar, A., Orringer, E., Bellevue, R., Olivieri, N., Eckman, J., et al. (2003) · JAMA · doi:10.1001/jama.289.13.1645 · Cited by 931
Self-citationA Specific Chemical Difference Between the Globins of Normal Human and Sickle-Cell Anæmia Hæmoglobin
INGRAM, V. M. (1956) · Nature · doi:10.1038/178792a0 · Cited by 896
Kato, G. J., Gladwin, M. T., & Steinberg, M. H. (2007) · Blood Reviews · doi:10.1016/j.blre.2006.07.001 · Cited by 876
Self-citation(1973) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1973.tb111034.x · Cited by 811
Protective effects of the sickle cell gene against malaria morbidity and mortality
Aidoo, M., Terlouw, D. J., Kolczak, M. S., McElroy, P. D., ter Kuile, F. O., Kariuki, S., Nahlen, B. L., Lal, A. A., & Udhayakumar, V. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08273-9 · Cited by 700
The Use of Transcranial Ultrasonography to Predict Stroke in Sickle Cell Disease
Adams, R., McKie, V., Nichols, F., Carl, E., Zhang, D.-L., McKie, K., Figueroa, R., Litaker, M., Thompson, W., & Hess, D. (1992) · New England Journal of Medicine · doi:10.1056/nejm199202273260905 · Cited by 658
Vichinsky, E. P., Haberkern, C. M., Neumayr, L., Earles, A. N., Black, D., Koshy, M., Pegelow, C., Abboud, M., Ohene-Frempong, K., & Iyer, R. V. (1995) · New England Journal of Medicine · doi:10.1056/nejm199507273330402 · Cited by 649
Daily Assessment of Pain in Adults with Sickle Cell Disease
Smith, W. R., Penberthy, L. T., Bovbjerg, V. E., McClish, D. K., Roberts, J. D., Dahman, B., Aisiku, I. P., Levenson, J. L., & Roseff, S. D. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-2-200801150-00004 · Cited by 648
Sickle Cell Hemoglobin Polymerization
Eaton, W. A., & Hofrichter, J. (1990) · Advances in Protein Chemistry · doi:10.1016/s0065-3233(08)60287-9 · Cited by 623
Alloimmunization in Sickle Cell Anemia and Transfusion of Racially Unmatched Blood
Vichinsky, E. P., Earles, A., Johnson, R. A., Hoag, M. S., Williams, A., & Lubin, B. (1990) · New England Journal of Medicine · doi:10.1056/nejm199006073222301 · Cited by 585
Correction of sickle cell disease in transgenic mouse models by gene therapy
Pawliuk, R., Westerman, K. A., Fabry, M. E., Payen, E., Tighe, R., Bouhassira, E. E., Acharya, S. A., Ellis, J., London, I. M., Eaves, C. J., et al. (2001) · Science · doi:10.1126/science.1065806 · Cited by 579 · cited 1×
“Gene therapy has “cured” sickle cell disease and thalassemia in mice engineered to have these disorders[229,230].”
BackgroundAcute Chest Syndrome in Sickle Cell Disease: Clinical Presentation and Course
Vichinsky, E. P., Styles, L. A., Colangelo, L. H., Wright, E. C., Castro, O., Nickerson, B., & Disease, T. C. S. O. S. C. (1997) · Blood · doi:10.1182/blood.v89.5.1787 · Cited by 573 · cited 1×
“Characterized by fever, chest pain, wheezing, cough, hypoxia, and a new lung infiltrate, this sometimes lethal complication affects more than half of all sickle cell anemia patients, is the second most common reason for hospitalization, and is a frequent cause of death in adults[92,93].”
BackgroundOutcome of Sickle Cell Anemia: A 4-Decade Observational Study of 1056 Patients
Powars, D. R., Chan, L. S., Hiti, A., Ramicone, E., & Johnson, C. (2005) · Medicine · doi:10.1097/01.md.0000189089.45003.52 · Cited by 558
Rosse, W., Gallagher, D., Kinney, T., Castro, O., Dosik, H., Moohr, J., Wang, W., & Levy, P. (1990) · Blood · doi:10.1182/blood.v76.7.1431.1431 · Cited by 524
Hebbel, R. P., Boogaerts, M. A. B., Eaton, J. W., & Steinberg, M. H. (1980) · New England Journal of Medicine · doi:10.1056/nejm198005013021803 · Cited by 518
Self-citationKinetics of sickle hemoglobin polymerization
Ferrone, F. A., Hofrichter, J., & Eaton, W. A. (1985) · Journal of Molecular Biology · doi:10.1016/0022-2836(85)90175-5 · Cited by 502
Primary role for adherent leukocytes in sickle cell vascular occlusion: A new paradigm
Turhan, A., Weiss, L. A., Mohandas, N., Coller, B. S., & Frenette, P. S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052522799 · Cited by 489
The Endothelial Biology of Sickle Cell Disease: Inflammation and a Chronic Vasculopathy
HEBBEL, R. P., OSAROGIAGBON, R., & KAUL, D. (2004) · Microcirculation · doi:10.1080/10739680490278402 · Cited by 463
Disorders of hemoglobin genetics, pathophysiology, and clinical management
Steinberg, M. H. (2001) · Cited by 438
Self-citationFrenette, P. S., Denis, C. V., Weiss, L., Jurk, K., Subbarao, S., Kehrel, B., Hartwig, J. H., Vestweber, D., & Wagner, D. D. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.8.1413 · Cited by 435
Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management
Somervaille, T. (2001) · Journal of the Royal Society of Medicine · doi:10.1177/014107680109401119 · Cited by 432
Anthropological Implications of Sickle Cell Gene Distribution in West Africa1
LIVINGSTONE, F. B. (1958) · American Anthropologist · doi:10.1525/aa.1958.60.3.02a00110 · Cited by 429
Kinney, T. R., Helms, R. W., O’Branski, E. E., Ohene‐Frempong, K., Wang, W. C., Daeschner, C., Vichinsky, E. P., Redding‐Lallinger, R., Gee, B. E., Platt, O. S., et al. (1999) · PubMed · Cited by 417
Fetal hemoglobin in sickle cell anemia: determinants of response to hydroxyurea
Steinberg, M. H., Lu, Z.-H., Barton, F. B., Terrin, M. L., Charache, S., Dover, G. J., & Hydroxyurea, T. M. S. O. (1997) · Blood · doi:10.1182/blood.v89.3.1078 · Cited by 407
Self-citationSickle cell disease: old discoveries, new concepts, and future promise
Frenette, P. S., & Atweh, G. F. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30920 · Cited by 400
Sickle Cell Disease as a Cause of Osteonecrosis of the Femoral Head
Milner, P. F., Kraus, A. P., Sebes, J. I., Sleeper, L. A., Dukes, K. A., Embury, S. H., Bellevue, R., Koshy, M., Moohr, J. W., & Smith, J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199111213252104 · Cited by 387
The biochemistry of nitric oxide, nitrite, and hemoglobin: role in blood flow regulation
Gladwin, M. T., Crawford, J. H., & Patel, R. P. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2003.11.032 · Cited by 378
Čokić, V. P., Smith, R. D., Beleslin‐Čokić, B. B., Njoroge, J. M., Miller, J. L., Gladwin, M. T., & Schechter, A. N. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16672 · Cited by 375
Walters, M. C., Storb, R. F., Patience, M., Leisenring, W. M., Taylor, T., Sanders, J. E., Buchanan, G. E., Rogers, Z. R., Dinndorf, P. A., Davies, S. C., et al. (2000) · PubMed · doi:10.1182/blood.v95.6.1918 · Cited by 361
Chronic Renal Failure in Sickle Cell Disease: Risk Factors, Clinical Course, and Mortality
Powars, D. R., Elliott-Mills, D. D., Chan, L., Niland, J., Hiti, A. L., Opas, L. M., & Johnson, C. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-8-614 · Cited by 360
Hydroxyurea and Sickle Cell Anemia Clinical Utility of a Myelosuppressive “Switching” Agent
Charache, S., Barton, F. B., Moore, R. D., Terrin, M. L., Steinberg, M. H., Dover, G. J., Ballas, S. K., McMahon, R. P., Castro, O., & Orringer, E. P. (1996) · Medicine · doi:10.1097/00005792-199611000-00002 · Cited by 335
Self-citationGenetic dissection and prognostic modeling of overt stroke in sickle cell anemia
Sebastiani, P., Ramoni, M. F., Nolan, V., Baldwin, C. T., & Steinberg, M. H. (2005) · Nature Genetics · doi:10.1038/ng1533 · Cited by 334
Self-citationMinneci, P. C. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25040 · Cited by 331
Arginine Therapy: A New Treatment for Pulmonary Hypertension in Sickle Cell Disease?
Morris, C. R., Morris, S. M., Hagar, W., van Warmerdam, J., Claster, S., Kepka-Lenhart, D., Machado, L., Kuypers, F. A., & Vichinsky, E. P. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200208-967oc · Cited by 329
Allison, A. C. (1954) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(54)90101-7 · Cited by 329
Neufeld, E. J. (2006) · Blood · doi:10.1182/blood-2006-02-002394 · Cited by 315
Zimmerman, S. A., Schultz, W. H., Davis, J. S., Pickens, C. V., Mortier, N. A., Howard, T. A., & Ware, R. E. (2004) · Blood · doi:10.1182/blood-2003-07-2475 · Cited by 313
Pathophysiology and treatment of stroke in sickle-cell disease: present and future
Switzer, J. A., Hess, D. C., Nichols, F. T., & Adams, R. J. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70469-0 · Cited by 309
Unraveling the Reactions of Nitric Oxide, Nitrite, and Hemoglobin in Physiology and Therapeutics
Kim-Shapiro, D. B., Schechter, A. N., & Gladwin, M. T. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000204350.44226.9a · Cited by 308
Pulmonary hypertension in patients with sickle cell disease: a longitudinal study
Ataga, K. I., Moore, C. G., Jones, S., Olajide, O., Strayhorn, D., Hinderliter, A., & Orringer, E. P. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06110.x · Cited by 298
Kinetics of sickle hemoglobin polymerization
Ferrone, F. A., Hofrichter, J., & Eaton, W. A. (1985) · Journal of Molecular Biology · doi:10.1016/0022-2836(85)90174-3 · Cited by 288
Beyond hemoglobin polymerization: the red blood cell membrane and sickle disease pathophysiology
Hebbel, R. (1991) · Blood · doi:10.1182/blood.v77.2.214.214 · Cited by 286
Swerlick, R., Eckman, Jr., Kumar, A., Jeitler, M., & Wick, T. (1993) · Blood · doi:10.1182/blood.v82.6.1891.1891 · Cited by 276
Circumstances of death in adult sickle cell disease patients
Darbari, D. S., Kple-Faget, P., Kwagyan, J., Rana, S., Gordeuk, V. R., & Castro, O. (2006) · American Journal of Hematology · doi:10.1002/ajh.20685 · Cited by 276
Brawley, O. W., Cornelius, L. J., Edwards, L. R., Gamble, V. N., Green, B. L., Inturrisi, C., James, A. H., Laraque, D., Mendez, M., Montoya, C. J., et al. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-12-200806170-00220 · Cited by 272
Heme oxygenase-1 is a modulator of inflammation and vaso-occlusion in transgenic sickle mice
Belcher, J. D. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26857 · Cited by 265
Phosphodiesterase-5A dysregulation in penile erectile tissue is a mechanism of priapism
Champion, H. C., Bivalacqua, T. J., Takimoto, E., Kass, D. A., & Burnett, A. L. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407183102 · Cited by 261
Halasa, N. B., Shankar, S. M., Talbot, T. R., Arbogast, P. G., Mitchel, E. F., Wang, W. C., Schaffner, W., Craig, A. S., & Griffin, M. R. (2007) · Clinical Infectious Diseases · doi:10.1086/516781 · Cited by 253
Hydroxyurea in the treatment of sickle-cell anemia.
Lw, H., & Kennedy, L. D. (1997) · PubMed · Cited by 251
Scothorn, D. J., Price, C., Schwartz, D., Terrill, C., Buchanan, G. R., Shurney, W., Sarniak, I., Fallon, R., Chu, J.-Y., Pegelow, C. H., et al. (2002) · The Journal of Pediatrics · doi:10.1067/mpd.2002.122498 · Cited by 247
Renal abnormalities in sickle cell disease
Ataga, K. I., & Orringer, E. P. (2000) · American Journal of Hematology · doi:10.1002/(sici)1096-8652(200004)63:4<205::aid-ajh8>3.0.co;2-8 · Cited by 247
Sickle cell disease vasculopathy: A state of nitric oxide resistance
Wood, K. C., Hsu, L. L., & Gladwin, M. T. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.01.008 · Cited by 246
De Castro, L. M., Jonassaint, J. C., Graham, F. L., Ashley‐Koch, A., & Telen, M. J. (2008) · American Journal of Hematology · doi:10.1002/ajh.21058 · Cited by 243
Leg ulcers in patients with sickle cell disease [see comments]
Koshy, M., Entsuah, R., Koranda, A., Kraus, A., Johnson, R., Bellvue, R., Flournoy-Gill, Z., & Levy, P. (1989) · Blood · doi:10.1182/blood.v74.4.1403.1403 · Cited by 241
P-selectin mediates the adhesion of sickle erythrocytes to the endothelium
Matsui, N. M., Borsig, L., Rosen, S. D., Yaghmai, M., Varki, A., & Embury, S. H. (2001) · Blood · doi:10.1182/blood.v98.6.1955 · Cited by 240
Concurrent Sickle-Cell Anemia and α-Thalassemia: Effect on Severity of Anemia
Embury, S. H., Dozy, A. M., Miller, J., Davis, J. R., Kleman, K. M., Preisler, H., Vichinsky, E., Lande, W. N., Lubin, B. H., Kan, Y. W., et al. (1982) · New England Journal of Medicine · doi:10.1056/nejm198202043060504 · Cited by 237
Ataga, K. I., Smith, W. R., De Castro, L. M., Swerdlow, P., Saunthararajah, Y., Castro, O., Vichinsky, E., Kutlar, A., Orringer, E. P., Rigdon, G. C., et al. (2008) · Blood · doi:10.1182/blood-2007-08-110098 · Cited by 235
Renal abnormalities in sickle cell disease
Pham, P.-T. T., Pham, P.-C. T., Wilkinson, A. H., & Lew, S. Q. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00806.x · Cited by 234
Nitric oxide donor properties of hydroxyurea in patients with sickle cell disease
Gladwin, M. T., Shelhamer, J. H., Ognibene, F. P., Pease‐Fye, M. E., Nichols, J. S., Link, B., Patel, D. B., Jankowski, M. A., Pannell, L. K., Schechter, A. N., et al. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03274.x · Cited by 234
Adhesion of normal and sickle erythrocytes to endothelial monolayer cultures
Hoover, R., Rubin, R., Wise, G., & Warren, R. (1979) · Blood · doi:10.1182/blood.v54.4.872.872 · Cited by 233
Bernini, J. C., Rogers, Z. R., Sandler, E. S., Reisch, J. S., Quinn, C. T., & Buchanan, G. R. (1998) · Blood · doi:10.1182/blood.v92.9.3082 · Cited by 230
Kaul, D. K., Fabry, M. E., Windisch, P., Baez, S., & Nagel, R. L. (1983) · Journal of Clinical Investigation · doi:10.1172/jci110960 · Cited by 225
Emerging role of nitrite in human biology
Dejam, A., Hunter, C. J., Schechter, A. N., & Gladwin, M. T. (2004) · Blood Cells, Molecules, and Diseases · doi:10.1016/j.bcmd.2004.02.002 · Cited by 221
Irreversible deformation of the spectrin-actin lattice in irreversibly sickled cells.
Lux, S. E., John, K. M., & Karnovsky, M. J. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108549 · Cited by 220
Five years of experience with hydroxyurea in children and young adults with sickle cell disease
Ferster, A., Tahriri, P., Vermylen, C., Sturbois, G., Corazza, F., Fondu, P., Devalck, C., Dresse, M. F., Feremans, W., Hunninck, K., et al. (2001) · Blood · doi:10.1182/blood.v97.11.3628 · Cited by 220
Udani, M., Zen, Q., Cottman, M., Leonard, N., Jefferson, S., Daymont, C., Truskey, G., & Telen, M. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1204 · Cited by 218
Combined therapy with deferiprone and desferrioxamine
Wonke, Wright, & Hoffbrand (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.01002.x · Cited by 218
Hemolysis-associated priapism in sickle cell disease
Nolan, V. G., Wyszynski, D. F., Farrer, L. A., & Steinberg, M. H. (2005) · Blood · doi:10.1182/blood-2005-04-1594 · Cited by 215
Self-citationMorris, C. R., Kuypers, F. A., Larkin, S., Vichinsky, E. P., & Styles, L. A. (2000) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-200011000-00009 · Cited by 213
Sildenafil therapy in patients with sickle cell disease and pulmonary hypertension
Machado, R. F., Martyr, S., Kato, G. J., Barst, R. J., Anthi, A., Robinson, M. R., Hunter, L., Coles, W., Nichols, J., Hunter, C., et al. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05625.x · Cited by 212
Sickle cell-related pain: Perceptions of medical practitioners
Shapiro, B. S., Benjamin, L. J., Payne, R., & Heidrich, G. (1997) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(97)00019-5 · Cited by 211
Thrombospondin mediates adherence of CD36+ sickle reticulocytes to endothelial cells
Sugihara, K., Sugihara, T., Mohandas, N., & Hebbel, R. (1992) · Blood · doi:10.1182/blood.v80.10.2634.2634 · Cited by 208
Discontinuing penicillin prophylaxis in children with sickle cell anemia
Falletta, J. M., Woods, G. M., Verter, J. I., Buchanan, G. R., Pegelow, C. H., Iyer, R. V., Miller, S. T., Holbrook, C. T., Kinney, T. R., Vichinsky, E., et al. (1995) · The Journal of Pediatrics · doi:10.1016/s0022-3476(95)70154-0 · Cited by 207
Joneckis, C., Ackley, R., Orringer, E., Wayner, E., & Parise, L. (1993) · Blood · doi:10.1182/blood.v82.12.3548.3548 · Cited by 203
Claster, S., & Vichinsky, E. P. (2003) · BMJ · doi:10.1136/bmj.327.7424.1151 · Cited by 198
Orringer, E. P., Casella, J. F., Ataga, K. I., Koshy, M., Adams-Graves, P., Luchtman-Jones, L., Wun, T., Watanabe, M., Shafer, F., Kutlar, A., et al. (2001) · JAMA · doi:10.1001/jama.286.17.2099 · Cited by 197
Self-citationBONE MARROW TRANSPLANTATION IN FIVE CHILDREN WITH SICKLE CELL ANAEMIA
Vermylen, C., Ninane, J., Fernandez Robles, E., & Cornu, G. (1988) · The Lancet · doi:10.1016/s0140-6736(88)92239-8 · Cited by 196
Morris, C. R., Suh, J. H., Hagar, W., Larkin, S., Bland, D. A., Steinberg, M. H., Vichinsky, E. P., Shigenaga, M., Ames, B., Kuypers, F. A., et al. (2008) · Blood · doi:10.1182/blood-2007-04-081703 · Cited by 191
Self-citationSolovey, A., Kollander, R., Shet, A., Milbauer, L. C., Choong, S., Panoskaltsis-Mortari, A., Blazar, B. R., Kelm, R. J., & Hebbel, R. P. (2004) · Blood · doi:10.1182/blood-2003-10-3719 · Cited by 191
Barriers to bone marrow transplantation for sickle cell anemia.
Walters, M., Patience, M., Leisenring, W. M., Eckman, J. R., Buchanan, G. R., Rogers, Z. R., Olivieri, N. F., Vichinsky, E. P., Davies, S. C., Mentzer, W. C., et al. (1996) · PubMed · Cited by 189
Sickle cell anemia day hospital: an approach for the management of uncomplicated painful crises
Benjamin, L. J., Swinson, G. I., & Nagel, R. L. (2000) · Blood · doi:10.1182/blood.v95.4.1130.003k03a_1130_1136 · Cited by 187
Pulmonary hypertension in sickle cell disease
Sutton, L. L., Castro, O., Cross, D. J., Spencer, J. E., & Lewis, J. F. (1994) · The American Journal of Cardiology · doi:10.1016/0002-9149(94)90760-9 · Cited by 184
The Irreversibly Sickled Cell; a Determinant of Haemolysis in Sickle Cell Anaemia
Serjeant, G. R., Serjeant, B. E., & Milner, P. F. (1969) · British Journal of Haematology · doi:10.1111/j.1365-2141.1969.tb01403.x · Cited by 184
Taylor, J. G., Nolan, V. G., Mendelsohn, L., Kato, G. J., Gladwin, M. T., & Steinberg, M. H. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002095 · Cited by 184
Self-citationFung, E. B., Harmatz, P. R., Lee, P. D. K., Milet, M., Bellevue, R., Jeng, M. R., Kalinyak, K. A., Hudes, M., Bhatia, S., Vichinsky, E. P., et al. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06332.x · Cited by 184
Kaul, D. K., Tsai, H. M., Liu, X. D., Nakada, M. T., Nagel, R. L., & Coller, B. S. (2000) · Blood · doi:10.1182/blood.v95.2.368 · Cited by 183
Steinberg, M., & Embury, S. (1986) · Blood · doi:10.1182/blood.v68.5.985.985 · Cited by 180
Self-citationBelcher, J. D., Mahaseth, H., Welch, T. E., Vilback, A. E., Sonbol, K. M., Kalambur, V. S., Bowlin, P. R., Bischof, J. C., Hebbel, R. P., & Vercellotti, G. M. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00986.2004 · Cited by 180
Weiner, D. L., Hibberd, P. L., Betit, P., Cooper, A. B., Botelho, C. A., & Brugnara, C. (2003) · JAMA · doi:10.1001/jama.289.9.1136 · Cited by 178
A two-year pilot trial of hydroxyurea in very young children with sickle-cell anemia
Wang, W. C., Wynn, L. W., Rogers, Z. R., Scott, J. P., Lane, P. A., & Ware, R. E. (2001) · The Journal of Pediatrics · doi:10.1067/mpd.2001.119590 · Cited by 178
Nolan, V. G., Adewoye, A., Baldwin, C., Wang, L., Ma, Q., Wyszynski, D. F., Farrell, J. J., Sebastiani, P., Farrer, L. A., & Steinberg, M. H. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06074.x · Cited by 172
Self-citationSedgewick, A. E., Timofeev, N., Sebastiani, P., So, J. C. C., Ma, E. S. K., Chan, L. C., Fucharoen, G., Fucharoen, S., Barbosa, C. G., Vardarajan, B. N., et al. (2008) · Blood Cells, Molecules, and Diseases · doi:10.1016/j.bcmd.2008.06.007 · Cited by 172
Self-citationStroke in sickle cell disease: demographic, clinical, and therapeutic considerations.
Ohene‐Frempong, K. (1991) · PubMed · Cited by 171
A Phase I/II Clinical Trial of β‐Globin Gene Therapy for β‐Thalassemia
BANK, A., DORAZIO, R., & LEBOULCH, P. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1345.007 · Cited by 169
Griffin, T. C., McIntire, D., & Buchanan, G. R. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403173301101 · Cited by 169
Gulbis, B. (2005) · Blood · doi:10.1182/blood-2004-07-2704 · Cited by 165
Pain Management of Sickle Cell Disease
Ballas, S. K. (2005) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2005.07.008 · Cited by 165
Successful treatment of murine β-thalassemia intermedia by transfer of the human β-globin gene
May, C., Rivella, S., Chadburn, A., & Sadelain, M. (2002) · Blood · doi:10.1182/blood.v99.6.1902 · Cited by 164
Al‐Refaie, F. N., Hershko, C., Hoffbrand, A. V., Kosaryan, M., Olivieri, N. F., Tondury, P., & Wonke, B. (1995) · British Journal of Haematology · doi:10.1111/j.1365-2141.1995.tb05274.x · Cited by 164
Bernaudin, F., Verlhac, S., Chevret, S., Torres, M., Coic, L., Arnaud, C., Kamdem, A., Hau, I., Grazia Neonato, M., & Delacourt, C. (2008) · Blood · doi:10.1182/blood-2008-03-143891 · Cited by 162
The pathophysiology of vascular obstruction in the sickle syndromes
Kaul, D. K., Fabry, M. E., & Nagel, R. L. (1996) · Blood Reviews · doi:10.1016/s0268-960x(96)90018-1 · Cited by 161
Haberkern, C. M., Neumayr, L., Orringer, E. P., Earles, A. N., Robertson, S., Black, D., Abboud, M. R., Koshy, M., Idowu, O., & Vichinsky, E. P. (1997) · PubMed · doi:10.1182/blood.v89.5.1533 · Cited by 160
Phagocytosis of sickle erythrocytes: immunologic and oxidative determinants of hemolytic anemia
Hebbel, R., & Miller, W. (1984) · Blood · doi:10.1182/blood.v64.3.733.733 · Cited by 158
Release of spectrin-free spicules on reoxygenation of sickled erythrocytes
Allan, D., Limbrick, A. R., Thomas, P., & Westerman, M. P. (1982) · Nature · doi:10.1038/295612a0 · Cited by 156
Modulation of endothelial cell activation in sickle cell disease: a pilot study
Solovey, A., Solovey, A. N., Harkness, J., & Hebbel, R. P. (2001) · Blood · doi:10.1182/blood.v97.7.1937 · Cited by 156
Zennadi, R., Hines, P. C., Castro, L. M. D., Cartron, J., Parise, L. V., & Telen, M. J. (2004) · Blood · doi:10.1182/blood-2004-01-0042 · Cited by 153
Sickle cell disease and the kidney
Scheinman, J. I. (2008) · Nature Reviews Nephrology · doi:10.1038/ncpneph1008 · Cited by 152
Pulmonary hypertension in sickle cell disease
Ataga, K. I., Sood, N., Gent, G. D., Kelly, E. A., Henderson, A. G., Jones, S., Strayhorn, D., Lail, A. E., Lieff, S., & Orringer, E. P. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.03.034 · Cited by 151
Vanillin, a potential agent for the treatment of sickle cell anemia
Abraham, D., Mehanna, A., Wireko, F., et al. (1991) · Blood · doi:10.1182/blood.v77.6.1334.1334 · Cited by 145
Burnett, A. L. “., Bivalacqua, T. J., Champion, H. C., & Musicki, B. (2006) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2006.00333.x · Cited by 145
Individual variation in the production and survival of F cells in sickle-cell disease
Dover, G. J., Boyer, S. H., Charache, S., & Heintzelman, K. (1978) · New England Journal of Medicine · doi:10.1056/nejm197812282992603 · Cited by 144 · cited 1×
“HbF concentrations vary among patients with sickle cell anemia and among erythrocytes of each individual[32,33].”
BackgroundFetal hemoglobin in sickle cell anemia: genetic determinants of response to hydroxyurea
Ma, Q., Wyszynski, D. F., Farrell, J. J., Kutlar, A., Farrer, L. A., Baldwin, C. T., & Steinberg, M. H. (2007) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500433 · Cited by 144
Self-citationDeSimone, J., Koshy, M., Dorn, L., Lavelle, D., Bressler, L. R., Molokie, R. E., & Talischy, N. (2002) · Blood · doi:10.1182/blood.v99.11.3905 · Cited by 143
Neumayr, L., Aguilar, C., Earles, A. N., et al. (2006) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.e.01454 · Cited by 142
Sultana, C., Shen, Y. M., Rattan, V., Johnson, C. S., & Kalra, V. K. (1998) · Blood · doi:10.1182/blood.v92.10.3924 · Cited by 137
Comparison of organ dysfunction in transfused patients with SCD or β thalassemia
Vichinsky, E. P., Butensky, E., Fung, E. B., Hudes, M. L., Theil, E. C., Ferrell, L. D., Williams, R., Louie, L. G., Lee, P., & Harmatz, P. (2005) · American Journal of Hematology · doi:10.1002/ajh.20402 · Cited by 137
Hillery, C. A., Du, M. C., Wang, W. C., & Scott, J. P. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02040.x · Cited by 132
Characterization of the phosphatidylserine-exposing subpopulation of sickle cells
de Jong, K., Larkin, S. K., Styles, L. A., Bookchin, R. M., & Kuypers, F. A. (2001) · Blood · doi:10.1182/blood.v98.3.860 · Cited by 132
Current Issues in Sickle Cell Pain and Its Management
Ballas, S. K. (2007) · Hematology · doi:10.1182/asheducation-2007.1.97 · Cited by 131
STILBOESTROL AND STUTTERING PRIAPISM IN HOMOZYGOUS SICKLE-CELL DISEASE
Serjeant, G. R., Ceulaer, K. D., & Maude, G. H. (1985) · The Lancet · doi:10.1016/s0140-6736(85)91555-7 · Cited by 128
Aliyu, Z. Y., Kato, G. J., Taylor, J. G., Babadoko, A., Mamman, A. I., Gordeuk, V. R., & Gladwin, M. T. (2007) · American Journal of Hematology · doi:10.1002/ajh.21057 · Cited by 127
Long-term oral phosphodiesterase 5 inhibitor therapy alleviates recurrent priapism
Burnett, A. L. “., Bivalacqua, T. J., Champion, H. C., & Musicki, B. (2006) · Urology · doi:10.1016/j.urology.2005.11.045 · Cited by 126
Derchi, G., Forni, G. L., Formisano, F., Cappellini, Galanello, R., D'Ascola, G., Bina, P., Magnano, C., & Lamagna, M. (2005) · PubMed · Cited by 125
Alpha thalassemia and stroke risk in sickle cell anemia
Adams, R. J., Kutlar, A., McKie, V. C., Carl, E., Nichols, F. T., Liu, J. C., McKie, K., & Clary, A. R. (1994) · American Journal of Hematology · doi:10.1002/ajh.2830450402 · Cited by 124
Qari, M. H., Jaouni, S. K. A., Alardawi, M. S., Fatani, H., Alsayes, F. M., Zografos, P., Alsaigh, M. A., Alalfi, A., Alamin, M. A., Gadi, A., et al. (2007) · Thrombosis and Haemostasis · doi:10.1160/th06-12-0718 · Cited by 124
Heparin inhibits the flow adhesion of sickle red blood cells to P-selectin
Matsui, N. M., Varki, A., & Embury, S. H. (2002) · Blood · doi:10.1182/blood-2002-02-0626 · Cited by 123
A Randomized Trial of Captopril for Microalbuminuria in Normotensive Adults with Sickle Cell Anemia
Foucan, L., Bourhis, V. M., Bangou, J., Mérault, L., Etienne‐Julan, M., & Salmi, L. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00056-4 · Cited by 120
Strouse, J. J., Takemoto, C. M., Keefer, J. R., Kato, G. J., & Casella, J. F. (2007) · Pediatric Blood & Cancer · doi:10.1002/pbc.21336 · Cited by 119
PULMONARY HYPERTENSION IN SICKLE CELL DISEASE: Relevance to Children
Kato, G. J., Onyekwere, O. C., & Gladwin, M. T. (2007) · Pediatric Hematology and Oncology · doi:10.1080/08880010601185892 · Cited by 116
Hemolysis in Sickle Cell Disease
Bensinger, T. A. (1974) · Archives of Internal Medicine · doi:10.1001/archinte.1974.00320160118010 · Cited by 113
Oral magnesium pidolate: effects of long‐term administration in patients with sickle cell disease
Franceschi, M. S. D., Bachir, Galacteros, Tchernia, Cynober, Neuberg, Beuzard, & Brugnara, C. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.01861.x · Cited by 111
Poillon, W. N., Kim, B. C., Rodgers, G. P., Noguchi, C. T., & Schechter, A. N. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.11.5039 · Cited by 111
Clinically silent primary adrenal lymphoma: A case report and review of the literature
Wang, J., Sun, N. C. J., Renslo, R., Chuang, C., Tabbarah, H. J., Barajas, L., & French, S. W. (1998) · American Journal of Hematology · doi:10.1002/(sici)1096-8652(199806)58:2<117::aid-ajh5>3.0.co;2-v · Cited by 110
Benkerrou, M., Delarche, C., Brahimi, L., Fay, M., Vilmer, E., Elion, J., Gougerot-Pocidalo, M.-A., & Elbim, C. (2002) · Blood · doi:10.1182/blood.v99.7.2297 · Cited by 110
Hydroxyurea nitrosylates and activates soluble guanylyl cyclase in human erythroid cells
Čokić, V. P., Andrić, S. A., Stojilković, S. S., Noguchi, C. T., & Schechter, A. N. (2007) · Blood · doi:10.1182/blood-2007-05-088732 · Cited by 107
Secretory phospholipase A2 predicts impending acute chest syndrome in sickle cell disease
Styles, L. A., Aarsman, A. J., Vichinsky, E. P., & Kuypers, F. A. (2000) · Blood · doi:10.1182/blood.v96.9.3276 · Cited by 105
Sickle cell bone disease: Response to vitamin D and calcium
Adewoye, A. H., Chen, T. C., Ma, Q., McMahon, L. C., Mathieu, J. S., Malabanan, A. O., Steinberg, M. H., & Holick, M. F. (2007) · American Journal of Hematology · doi:10.1002/ajh.21085 · Cited by 104
Self-citationBallas, S. K. (1991) · American Journal of Hematology · doi:10.1002/ajh.2830360211 · Cited by 103
Hsu, L. L.-Y., Miller, S. T., Wright, E. C., Kutlar, A., McKie, V. C., Wang, W. C., Pegelow, C. H., Driscoll, C., Hurlet, A., Woods, G. M., et al. (2003) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-200308000-00007 · Cited by 103
Chang, J., Shi, P. A., Chiang, E. Y., & Frenette, P. S. (2007) · Blood · doi:10.1182/blood-2007-04-084061 · Cited by 101
Mortality in sickle cell patients on hydroxyurea therapy
Bakanay, Ş. M., Dainer, E., Clair, B., Adekile, A. D., Daitch, L., Wells, L., Holley, L., Smith, D. A., & Kutlar, A. (2004) · Blood · doi:10.1182/blood-2004-01-0322 · Cited by 100
Short-chain fatty acid derivatives induce fetal globin expression and erythropoiesis in vivo
Pace, B. S., White, G. L., Dover, G. J., Boosalis, M. S., Faller, D. V., & Perrine, S. P. (2002) · Blood · doi:10.1182/blood-2002-02-0353 · Cited by 97
Kinetics of sickle haemoglobin polymerization in single red cells
Coletta, M., Hofrichter, J., Ferrone, F. A., & Eaton, W. A. (1982) · Nature · doi:10.1038/300194a0 · Cited by 96
Turhan, A., Jenab, P., Bruhns, P., Ravetch, J. V., Coller, B. S., & Frenette, P. S. (2003) · Blood · doi:10.1182/blood-2003-07-2209 · Cited by 93
Common genetic disorders of the red cell and the ‘malaria hypothesis’
Weatherall, D. J. (1987) · Annals of Tropical Medicine and Parasitology · doi:10.1080/00034983.1987.11812155 · Cited by 91
Wood, K. C., Hebbel, R. P., Lefer, D. J., & Granger, D. N. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.12.015 · Cited by 91
Butyrate increases the efficiency of translation of γ-globin mRNA
Weinberg, R. S., Ji, X., Sutton, M., Perrine, S. P., Galperin, Y., Li, Q., Liebhaber, S. A., Stamatoyannopoulos, G., & Atweh, G. F. (2004) · Blood · doi:10.1182/blood-2004-02-0454 · Cited by 88
Pulmonary Hypertension in Sickle Cell Disease: Mechanisms, Diagnosis, and Management
Castro, O. L., & Gladwin, M. T. (2005) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2005.07.007 · Cited by 87
Niihara, Y., Matsui, N. M., Shen, Y. M., Akiyama, D. A., Johnson, C. S., Sunga, M. A., Magpayo, J., Embury, S. H., Kalra, V. K., Cho, S., et al. (2005) · BMC Hematology · doi:10.1186/1471-2326-5-4 · Cited by 86
Gladwin, M. T. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29807 · Cited by 85
Inhibition of sickle hemoglobin gelation by amino acids and related compounds
Noguchi, C. T., & Schechter, A. N. (1978) · Biochemistry · doi:10.1021/bi00618a020 · Cited by 83
Sickle cell disease and pregnancy
Koshy, M. (1995) · Blood Reviews · doi:10.1016/0268-960x(95)90021-7 · Cited by 82
Hydroxyurea reacts with heme proteins to generate nitric oxide
Pacelli, R., Taira, J., Cook, J. A., Wink, D. A., & Krishna, M. C. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91378-1 · Cited by 82
Transfusion prevents acute chest syndrome predicted by elevated secretory phospholipase A2
Styles, L. A., Abboud, M. R., Larkin, S. K., Lo, M. C., & Kuypers, F. A. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06409.x · Cited by 80
Development of gene therapy for blood disorders
Nienhuis, A. W. (2008) · Blood · doi:10.1182/blood-2007-11-078121 · Cited by 78
Catalase-Mediated Nitric Oxide Formation from Hydroxyurea
Huang, J., Kim‐Shapiro, D. B., & King, S. B. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030547z · Cited by 77
Brugnara, C. (2003) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-200312000-00004 · Cited by 75
Is “Relative” Hypertension a Risk Factor for Vaso-occlusive Complications in Sickle Cell Disease?
Rodgers, G. P., Walker, E. C., & Podgor, M. J. (1993) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199303000-00004 · Cited by 67
Genetic endothelial systems biology of sickle stroke risk
Milbauer, L. C., Wei, P., Enenstein, J., Jiang, A., Hillery, C. A., Scott, J. P., Nelson, S. C., Bodempudi, V., Topper, J. N., Yang, R., et al. (2007) · Blood · doi:10.1182/blood-2007-06-097188 · Cited by 66
Dose‐Escalation Study of ICA‐17043 in Patients with Sickle Cell Disease
Ataga, K. I., Orringer, E. P., Styles, L. A., Vichinsky, E. P., Swerdlow, P. S., Davis, G. A., DeSimone, P. A., & Stocker, J. W. (2006) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.26.11.1557 · Cited by 65
Increased soluble guanylate cyclase activity in the red blood cells of sickle cell patients
Conran, N., dos Santos, C. O., Acosta, H. C., Fattori, A., Saad, S. T. O., & Costa, F. F. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.04810.x · Cited by 65
Haldane, hot dogs, halitosis, and hypoxic vasodilation: the emerging biology of the nitrite anion
Gladwin, M. T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci20664 · Cited by 65
Effects of hydroxyurea on the membrane of erythrocytes and platelets in sickle cell anemia.
Covas, D. T., Ângulo, I. L., Palma, P. V. B., & Zago, M. A. (2004) · PubMed · Cited by 65
Pain Management in Sickle Cell Disease
Payne, R. (1989) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1989.tb24166.x · Cited by 64
Barabino, G. A., Liu, X. D., Ewenstein, B. M., & Kaul, D. K. (1999) · Blood · doi:10.1182/blood.v93.4.1422 · Cited by 63
Taylor, J. G., Ackah, D., Cobb, C., Orr, N., Percy, M. J., Sachdev, V., Machado, R. F., Castro, O. L., Kato, G. J., Chanock, S. J., et al. (2007) · American Journal of Hematology · doi:10.1002/ajh.21035 · Cited by 62
Fathallah, H., Weinberg, R. S., Galperin, Y., Sutton, M., & Atweh, G. F. (2007) · Blood · doi:10.1182/blood-2007-02-076091 · Cited by 61
Role of the Red Blood Cell in Nitric Oxide Homeostasis and Hypoxic Vasodilation
Gladwin, M. T. (2007) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-387-34817-9_17 · Cited by 59
Kumkhaek, C., Taylor, J. G., Zhu, J., Hoppe, C. C., Kato, G. J., & Rodgers, G. P. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07045.x · Cited by 57
Lopez, B. L., Davis‐Moon, L., Ballas, S. K., & Ma, X.-L. (2000) · American Journal of Hematology · Cited by 53
Klings, E. S., Bland, D. A., Rosenman, D., Princeton, S., Odhiambo, A., Li, G., Bernard, S. A., Steinberg, M. H., & Farber, H. W. (2008) · American Journal of Hematology · doi:10.1002/ajh.21187 · Cited by 52
Self-citationTreatment of pain in adults with sickle cell disease
Ballas, S. K. (1990) · American Journal of Hematology · doi:10.1002/ajh.2830340111 · Cited by 47
Polynitroxyl albumin inhibits inflammation and vasoocclusion in transgenic sickle mice
Mahaseth, H., Vercellotti, G. M., Welch, T. E., Bowlin, P. R., Sonbol, K. M., Hsia, C. J. C., Ma, L., Bischof, J. C., Hebbel, R. P., & Belcher, J. D. (2005) · Journal of Laboratory and Clinical Medicine · doi:10.1016/j.lab.2005.02.008 · Cited by 42
Nagel, R. L., & Steinberg, M. H. (2001) · Fetal and Pediatric Pathology · doi:10.1080/15513810109168606 · Cited by 42
Self-citationDipyridamole inhibits sickling-induced cation fluxes in sickle red blood cells
Joiner, C. H., Jiang, M., Claussen, W. J., Roszell, N. J., Yasin, Z., & Franco, R. S. (2001) · Blood · doi:10.1182/blood.v97.12.3976 · Cited by 39
Sickle Cell Disease and the Kidney
Scheinman, J. I. (2003) · Seminars in Nephrology · doi:10.1053/snep.2003.50006 · Cited by 39
Decreased plasma endothelin-1 levels in children with sickle cell disease treated with hydroxyurea.
Lapouméroulie, C., Benkerrou, M., Odièvre, M. H., Ducrocq, R., Brun, M., & Élion, J. (2005) · PubMed · Cited by 37
Dover, G., Chang, V., Boyer, S. H., Serjeant, G. R., Antonarakis, S. E., & Higgs, D. R. (1987) · Blood · doi:10.1182/blood.v69.1.341.341 · Cited by 36
Finnegan, E. M., Barabino, G. A., Liu, X.-D., Chang, H.-Y., Jonczyk, A., & Kaul, D. K. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01054.2006 · Cited by 34
Hydroxyurea Treatment for Sickle Cell Anemia
Al-Salem, A. H. (2015) · Springer eBooks · doi:10.1007/978-3-319-24762-5_21 · Cited by 32
Kaul, D. K., Liu, X.-D., & Nagel, R. L. (2001) · Blood · doi:10.1182/blood.v98.10.3128 · Cited by 30
DNA methylation and globin gene expression in patients treated with 5-azacytidine.
Ley, T. J., Anagnou, N., Noguchi, C. T., Schechter, A. N., DeSimone, J., Heller, P. G., & Nienhuis, A. (1983) · PubMed · Cited by 29
RENAL FAILURE IN SICKLE CELL ANEMIA
Wong, W.-Y., Elliott-Mills, D. D., & Powars, D. R. (1996) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(05)70403-2 · Cited by 28
Erythropoietin in Anemia of Renal Failure in Sickle Cell Disease
Roger, S. D., Macdougall, I. C., Thuraisingham, R. C., & Raine, A. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110173251614 · Cited by 26
A role for nitric oxide in hydroxyurea-mediated fetal hemoglobin induction
King, S. B. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17597 · Cited by 25
Haematopoietic cell transplantation in the treatment of sickle cell disease
Atkins, R. C., & Walters, M. C. (2003) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.3.8.1215 · Cited by 23
Cited by
Connolly, B. D., Petry, C., Yadav, S., Demeule, B., Ciaccio, N., Moore, J. M. R., Shire, S. J., & Gokarn, Y. R. (2012) · Biophysical Journal · doi:10.1016/j.bpj.2012.04.047 · Cited by 340
Keller, S. D., Yang, M., Treadwell, M. J., Werner, E. M., & Hassell, K. L. (2014) · Health and Quality of Life Outcomes · doi:10.1186/s12955-014-0125-0 · Cited by 115
“Variations include Hb-SS, Hb-SC and Hb-Sβ [11,12] and individuals with Hb-SS usually, but not always, have more symptoms than those with other genotypes [13-15].”
BackgroundSickle Cell Disease: From Genetics to Curative Approaches
Hardouin, G., Magrin, E., Corsia, A., Cavazzana, M., Miccio, A., & Semeraro, M. (2023) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-120122-081037 · Cited by 40
Alagbe, A. E., Justo Junior, A. S., Ruas, L. P., Tonassé, W. V., Santana, R. M., Batista, T. H. C., Domingos, I. F., Araujo, A. S., Bezerra, M. A. C., Santos, M. N. N., et al. (2018) · Cytokine · doi:10.1016/j.cyto.2017.12.001 · Cited by 20
Metadata
- Authors
- Steinberg, M. H.
- Venue
- The Scientific World JOURNAL
- Publisher
- Hindawi Limited
- Published
- 2008
- Volume
- 8
- Pages
- 1295-1324
- ISSN
- 1537-744X (ISSN-L)
- OpenAlex
- W1992577724
- Cited by
- 293
- References
- 207
- FWCI
- 4.01
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.